Status:
NOT_YET_RECRUITING
Screening for Familial Hypercholesterolemia in Children
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Hypercholesterolemia, Familial
Eligibility:
All Genders
2-18 years
Phase:
NA
Brief Summary
Familial hypercholesterolemia is the most common treatable genetic disorder for which a simple, effective treatment is available, with few side effects. It leads to a significant increase in LDL leve...
Eligibility Criteria
Inclusion
- Age between 2 and 18 years
- Minimum 8-hour fasting
- Parents and children with signed informed consent
Exclusion
- Known familial hypercholesterolemia
- Diabetes less than one month old
- Profound hypothyroidism
- Acute nephrotic syndrome
- cancer under treatment
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06555120
Start Date
October 1 2024
End Date
February 1 2026
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Amiens
Amiens, France, 80480